CBT Latest Quarter's Earnings
| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $1.7 (Miss by $-0.02) |
| EPS GAAP Actual | $1.7 (Miss by $-0.02) |
| Revenue Actual | $0.923B |
| Revenue Surprise | Beat by $923M |
Upcoming Quarter's Earnings
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.99874 |
| EPS GAAP Estimate | $1.99874 |
| Revenue Estimate | $1.020833336B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2026 | 8.22426 | 7.48 | 7.94558 | 8.46055 | 1 |
| Sep 2025 | 7.25 | 8.48 | 7.08313 | 7.73909 | 2 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.89 | 1.89 | 0.923B | -10.08% | 923M |
| FQ1 2025 (Mar 2025) | 1.71 | 1.71 | 0.936B | -8.87% | 936M |
| FQ4 2024 (Dec 2024) | 1.71 | 1.71 | 0.955B | -0.31% | 955M |
| FQ3 2024 (Sep 2024) | 2.48 | 2.48 | 1.001B | 3.6% | 1001M |
| FQ2 2024 (Jun 2024) | 1.96 | 1.96 | 1.016B | 4.72% | 1016M |
| FQ1 2024 (Mar 2024) | 1.52 | 1.52 | 1.019B | -1.37% | 1019M |
| FQ4 2023 (Dec 2023) | 0.88 | 0.88 | 0.958B | -0.73% | 958M |
| FQ3 2023 (Sep 2023) | 4.24 | 4.24 | 0.965B | -15.23% | 965M |
Quarterly Estimates Summary
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
1.99874
Consensus Revenue Estimates
1.020833336B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 1.87705 | -- | 1.8333 | 1.91275 | 1 |
| FQ2 2028 (Jun 2028) | 2.01709 | -- | 1.97007 | 2.05545 | 1 |
| FQ1 2028 (Mar 2028) | 1.93391 | -- | 1.88883 | 1.97069 | 1 |
| FQ4 2027 (Dec 2027) | 1.5759 | -- | 1.53917 | 1.60587 | 1 |
| FQ3 2027 (Sep 2027) | 2.51871 | -- | 2.4778 | 2.55963 | 1 |
| FQ2 2027 (Jun 2027) | 2.39381 | -- | 2.35493 | 2.4327 | 1 |
| FQ1 2027 (Mar 2027) | 2.34973 | -- | 2.31156 | 2.3879 | 1 |
| FQ4 2026 (Oct 2026) | 2.06036 | -- | 2.01427 | 2.12123 | 1 |
| FQ3 2026 (Jul 2026) | 2.05267 | -- | 2.00675 | 2.11331 | 1 |
| FQ2 2026 (Jun 2026) | 2.07068 | 8.73 | 1.99561 | 2.15024 | 1 |
| FQ1 2026 (Mar 2026) | 2.33346 | 26.72 | 2.24887 | 2.42312 | 1 |
| FQ4 2025 (Dec 2025) | 1.99874 | 14.45 | 1.97379 | 2.03065 | 2 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 0.95B | -- | 0.93B | 0.96B | 1 |
| FQ2 2028 (Jun 2028) | 0.98B | -- | 0.96B | 0.99B | 1 |
| FQ1 2028 (Mar 2028) | 0.99B | -- | 0.98B | 1.01B | 1 |
| FQ4 2027 (Dec 2027) | 0.91B | -- | 0.89B | 0.92B | 1 |
| FQ3 2027 (Sep 2027) | 1.14B | -- | 1.12B | 1.15B | 1 |
| FQ2 2027 (Jun 2027) | 1.13B | -- | 1.12B | 1.15B | 1 |
| FQ1 2027 (Mar 2027) | 1.15B | -- | 1.13B | 1.16B | 1 |
| FQ4 2026 (Oct 2026) | 1.05B | -- | 1.03B | 1.08B | 1 |
| FQ3 2026 (Jul 2026) | 1.1B | -- | 1.08B | 1.12B | 1 |
| FQ2 2026 (Jun 2026) | 1.12B | 17.23 | 1.08B | 1.15B | 1 |
| FQ1 2026 (Mar 2026) | 1.2B | 22.18 | 1.17B | 1.24B | 1 |
| FQ4 2025 (Dec 2025) | 1.02B | 6.45 | 1.01B | 1.03B | 1 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.89 | 1.89 | 100% | |
| FQ1 2025 (Mar 2025) | 1.71 | 1.71 | 100% | |
| FQ4 2024 (Dec 2024) | 1.71 | 1.71 | 100% | |
| FQ3 2024 (Sep 2024) | 2.48 | 2.48 | 100% | |
| FQ2 2024 (Jun 2024) | 1.96 | 1.96 | 100% | |
| FQ1 2024 (Mar 2024) | 1.52 | 1.52 | 100% | |
| FQ4 2023 (Dec 2023) | 0.88 | 0.88 | 100% | |
| FQ3 2023 (Sep 2023) | 4.24 | 4.24 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.92B | $923M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.94B | $936M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.96B | $955M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1B | $1001M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.02B | $1016M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.02B | $1019M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.96B | $958M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0.97B | $965M | 100% |
CBT Ratings Summary
CBT Quant Ranking
